Impact of matrix metalloproteinase 9 rs3918242 genetic variant on lipid-lowering efficacy of simvastatin therapy in Chinese patients with coronary heart disease

Impact of matrix metalloproteinase 9 rs3918242 genetic variant on lipid-lowering efficacy of simvastatin therapy in Chinese patients with coronary heart disease

Abstract Background Genetic variation of matrix metalloproteinase 9 (MMP-9) gene polymorphism has been suggested to modulate coronary heart diseases (CHD), yet the underlying mechanisms are not well understood. Methods We investigated the association of MMP9 rs3918242 single nucleotide polymorphism...

Full description

Bibliographic Details
Main Authors: Yuanyuan Xu, Yan Wang, Jixin Zhi, Lichun Qi, Tong Zhang, Xueqi Li
Format: Article
Language:English
Published: BMC 2017-04-01
Series:BMC Pharmacology and Toxicology
Subjects:
HMG-CoA reductase inhibitor
Genetic polymorphism
MMP9
Coronary heart disease
Online Access:http://link.springer.com/article/10.1186/s40360-017-0132-y

Internet

http://link.springer.com/article/10.1186/s40360-017-0132-y

Similar Items